Medication management visits differ fundamentally from psychotherapy sessions, and the clinical note should reflect that difference. Where a therapy note documents the therapeutic process and the client's subjective experience, a medication management note is a structured medical record — closer in form to a primary care visit note than to a DAP or SOAP therapy note. Prescribing clinicians, whether psychiatrists, psychiatric nurse practitioners, or primary care providers managing psychiatric conditions, need documentation that is systematic, precise, and medically defensible.
Chief Complaint Since Last Visit
Every medication management note begins with the patient's own words about how they have been doing since the last appointment. This is not a clinician summary — it is a direct quotation or close paraphrase of what the patient reports. "I've been feeling less depressed but still can't sleep" or "The medication is making me gain weight and I want to stop" are the kinds of chief complaints that orient the reader immediately. If the patient reports no concerns, document that explicitly: "Patient reports doing well, no new complaints since last visit."
Review of Systems
A psychiatric medication management note includes both a psychiatric review of systems and a relevant physical review of systems. On the psychiatric side, you are documenting current symptom status across the relevant diagnostic domains — for a patient on an antidepressant, you are asking about mood, anhedonia, sleep, appetite, energy, concentration, worthlessness, and suicidality. For a patient on a mood stabilizer, you are also reviewing manic and hypomanic symptoms. On the physical side, you are reviewing systems relevant to medication safety — cardiovascular symptoms (palpitations, chest pain), gastrointestinal symptoms (nausea, diarrhea), neurological symptoms (tremor, headache), and any system relevant to the specific medications prescribed.
Current Medications with Doses
List every psychiatric medication the patient is currently taking, including the full dose and frequency. Do not write "continues current medications" — spell them out. Include any relevant non-psychiatric medications, particularly those with known drug-drug interactions with the patient's psychiatric regimen. This list must be accurate and current, because it becomes part of the legal medical record and guides future prescribers.
Medication Adherence Assessment
Document how consistently the patient has been taking their medications. Have they missed doses? If so, how many, and what were the circumstances? Do they take medications at the right time of day? Have they modified doses on their own? Non-adherence is clinically significant and must be documented without judgment. "Patient reports missing approximately 3 doses per week due to forgetting; denies intentional dose changes" gives the next clinician important context.
Efficacy Evaluation Using Validated Scales
This is arguably the most clinically important section of the note. Document current symptom severity using validated outcome measures whenever possible. The PHQ-9 for depression, GAD-7 for generalized anxiety, YMRS (Young Mania Rating Scale) for mania, and PCL-5 for PTSD are widely used and produce numerical scores that allow direct comparison over time. Document not just the current score but the trajectory: "PHQ-9 today is 8, down from 14 at last visit, consistent with moderate improvement in depressive symptoms." If you are not using formal scales, describe symptom changes in specific behavioral and functional terms — "patient reports returning to work three days per week, up from zero at intake" is more clinically useful than "patient feels somewhat better."
Side Effect Review and Management
Every medication management note must include documentation of side effect review. Go through the known side effect profile of each medication and document the patient's report. Common side effects to review include sedation, insomnia, weight changes, sexual dysfunction, GI symptoms, tremor, cognitive effects, and any medication-specific concerns (e.g., metabolic monitoring for atypical antipsychotics, renal function for lithium). When side effects are present, document their severity, impact on functioning, and your clinical management decision — dose adjustment, timing change, adjunctive treatment, or watchful waiting with the patient's informed agreement.
Laboratory Results and Orders
Document any labs ordered at this visit and any results reviewed. For patients on medications requiring monitoring — lithium levels, valproate levels, thyroid function, metabolic panels for second-generation antipsychotics, CBC for clozapine — the note must reflect that monitoring occurred. Document the result and whether it is within therapeutic range. If labs are due but not yet ordered, document the plan. Missing lab monitoring documentation creates significant liability exposure.
Medication Changes and Clinical Rationale
Any change to the medication regimen — new prescription, dose adjustment, discontinuation, substitution — must be documented with clinical rationale. "Increased sertraline from 100mg to 150mg daily due to persistent depressive symptoms with good tolerability at current dose" is complete documentation. "Discontinued olanzapine due to 15-pound weight gain over 3 months with patient preference to switch; transitioning to aripiprazole" explains both the clinical reason and patient participation in the decision. The rationale demonstrates medical decision-making and protects against allegations of arbitrary prescribing.
Patient Education Provided
Document what you taught the patient during the visit. This might include information about a new medication's expected onset and side effects, instructions about what to do if they miss a dose, guidance on alcohol interactions, or explanation of lab monitoring requirements. Documentation of education serves two purposes: it demonstrates that informed consent is an ongoing process, and it creates a record that supports malpractice defense if a patient later claims they were never told about a risk.
Risk Assessment
Every psychiatric medication management note must include at minimum a brief risk assessment documenting suicidal ideation, homicidal ideation, and any other relevant safety concerns. Even if the patient denies all suicidal ideation, document that denial explicitly: "Patient denies current suicidal ideation, intent, or plan. No homicidal ideation. No access to firearms." If risk is elevated, document the full risk assessment including static and dynamic factors, protective factors, and the clinical rationale for your management decision.
Plan and Follow-Up Interval
Close the note with a clear treatment plan and follow-up schedule. The follow-up interval should be clinically justified — stable patients on established medications might be seen every one to three months, while patients starting new medications or in unstable clinical states may need weekly or biweekly visits. Document the specific interval and any conditions that should prompt earlier contact. A complete plan also includes what the patient should do in a crisis between appointments.
Medication management notes are structured documents that reflect medical decision-making. Unlike therapy notes, which document a process, medication management notes document clinical status, treatment decisions, and monitoring — and they must be written to that higher standard of medical specificity.